| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.6B | $2.4B | $2.2B | $2.0B | — | $0.4B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | $0.1B |
| Net Income | $0.6B | $0.5B | $0.5B | $0.4B | $0.3B | $0.2B | $0.1B | $-0.1B |
| EPS (Basic) | $0.96 | $0.74 | $0.85 | $0.63 | $0.45 | $0.35 | $0.10 | $-0.26 |
| EPS (Diluted) | $0.96 | $0.74 | $0.85 | $0.63 | $0.45 | $0.35 | $0.10 | $-0.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.7B | $18.7B | $19.2B | $18.5B | $18.5B | $17.5B | $17.4B | $18.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.2B | $0.7B | $0.3B | $0.6B | $0.2B | $0.1B | $0.2B |
| Total Liabilities | $9.1B | $8.9B | $9.0B | $8.2B | $8.7B | $9.0B | $9.1B | $10.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $9.5B | $9.8B | $10.2B | $10.3B | $9.8B | $8.5B | $8.2B | $8.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.1B | $1.1B | $1.0B | $0.9B | $0.7B | $0.7B | $0.3B |
| Investing Cash Flow | $-0.7B | $-0.5B | $-0.8B | $-0.8B | $-1.2B | $-0.4B | $0.1B | $0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.0B |
| Financing Cash Flow | $-0.6B | $-1.1B | $0.1B | $-0.6B | $0.7B | $-0.1B | $-0.8B | $-0.3B |